Law Journal Breaking News: Irish and US firms line up for $160bn Pfizer/Allergan merger ~ lawyer,attorney,legal information
User-agent: * Allow: /

Search This Blog

SEARCH

Monday, November 23, 2015

Breaking News: Irish and US firms line up for $160bn Pfizer/Allergan merger


Legal Week | Breaking News
Irish and US firms line up for $160bn Pfizer/Allergan merger
News - Mon 23rd Nov
Cleary, Wachtell and Arthur Cox are among the firms helping to create the world's biggest pharmaceutical company
Legal Week Law Legal Briefings & Resources
Important news for UK leveraged renewables projects: proposed changes to tax treatment of debt interest
The UK Government has issued a consultation paper setting out proposals for UK tax deductions for interest paid on both third party debts to be capped. This represents a fundamental change to the UK taxation of debt with a potentially significant impact on UK leveraged renewable projects.
Download
More from Legal Week Law
Upcoming Events for Legal Professionals
The British Legal Awards 2015
Awards & Rankings - Wed 25th Nov 2015, London
The British Legal Awards are the leading awards for the UK's thriving business law community acting as a showcase for the achievements of one of the country's most successful sectors.
DetailsBook OnlineEnquriesAdd to Diary
2078 Legal Jobs from Legal Week Jobs
Private Client Lawyer NQ-2PQE GUERNSEY
Leaf Legal -Highly Competitive
Our client is seeking to expand its fiduciary/ private client team.You are likely to have done atleast a seat in private client or trusts work in a respected firm.Guernsey
More from Legal Week Jobs

AOP Digital Publisher of the Year 2010 & 2013

© Incisive Business Media (IP) Limited 2015, Published by Incisive Business Media Limited, Haymarket House, 28-29 Haymarket, London SW1Y 4RX, are companies registered in England and Wales with company registration numbers 9177174 & 9178013.

This email is intended for anjeri2010.lawyerinfo@blogger.com.

Update Details & Email Options

Add to Safe Senders  |  Contact  |  Privacy

Unsubscribe

0 comments:

Post a Comment